These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11330168)

  • 1. A new niacin. Vitamin with an HDL kick.
    US News World Rep; 2001 Apr; 130(15):54. PubMed ID: 11330168
    [No Abstract]   [Full Text] [Related]  

  • 2. [Safety and tolerability of nicotinic acid. Results of the multicenter, open, prospective NAUTILUS study].
    Vogt A; Kassner U; Hostalek U; Peiter A; Steinhagen-Thiessen E
    MMW Fortschr Med; 2006 May; 148(18):41. PubMed ID: 16736688
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of dyslipoproteinemia risk factor. Lipid therapy must become multidimensional].
    MMW Fortschr Med; 2008 Jun; 150(26-27):52-3. PubMed ID: 18681233
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging.
    Jaffer FA
    J Am Coll Cardiol; 2009 Nov; 54(19):1795-6. PubMed ID: 19874993
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
    Ballantyne CM; Davidson MH; McKenney J; Keller LH; Bajorunas DR; Karas RH
    Am J Cardiol; 2008 May; 101(10):1428-36. PubMed ID: 18471454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On call. In your January 2007 article on cholesterol, you said that no-flush niacin does not lower cholesterol levels. But my problem is low HDL cholesterol. Will no-flush niacin help my HDL even if it won't lower my LDL cholesterol?
    Simon HB
    Harv Mens Health Watch; 2007 Jun; 11(11):7-8. PubMed ID: 17644843
    [No Abstract]   [Full Text] [Related]  

  • 7. [Even if LDL and triglycerides are within normal limits, low HDL increases risk of infarction].
    MMW Fortschr Med; 2004 May; 146(21):59. PubMed ID: 15373089
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
    Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Back to basics. Cholesterol.
    Roberts SS
    Diabetes Forecast; 2005 Mar; 58(3):33-5. PubMed ID: 15806692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
    März W
    MMW Fortschr Med; 2005 Apr; 147(14):14. PubMed ID: 15887675
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary coronary heart disease prevention. Will CEPT inhibitors be the next breakthrough?].
    Einecke D
    MMW Fortschr Med; 2011 Dec; 153(49-50):17-8. PubMed ID: 22308584
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecule of the Month. TREDAPTIVE (nicotinic acid/laropiprant): a new lipid-modifying therapy for the treatment of LDL-C, HDL-C and triglycerides.
    Felts AS
    Curr Top Med Chem; 2008; 8(14):1310. PubMed ID: 18928015
    [No Abstract]   [Full Text] [Related]  

  • 14. Niacin revisited. A randomized, controlled trial of wax-matrix sustained-release niacin in hypercholesterolemia.
    Keenan JM; Fontaine PL; Wenz JB; Myers S; Huang ZQ; Ripsin CM
    Arch Intern Med; 1991 Jul; 151(7):1424-32. PubMed ID: 2064495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins are magic when you gotta have heart.
    Comarow A
    US News World Rep; 2001 Apr; 130(15):54-5. PubMed ID: 11330169
    [No Abstract]   [Full Text] [Related]  

  • 16. Choice of lipid-regulating drugs.
    Med Lett Drugs Ther; 2001 May; 43(1105):43-8. PubMed ID: 11378632
    [No Abstract]   [Full Text] [Related]  

  • 17. When taking niacin to help lower my LDL and raise my HDL, I have experienced a hot and itchy "flushing" sensation, which I understand is very common. Are there any "no flush" niacin products on the market?
    Heart Advis; 2007 Nov; 10(11):8. PubMed ID: 18271102
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis.
    Insull W; McGovern ME; Schrott H; Thompson P; Crouse JR; Zieve F; Corbelli J
    Arch Intern Med; 2004 May; 164(10):1121-7. PubMed ID: 15159270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of niacin.
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2008 Apr; 101(8A):20B-26B. PubMed ID: 18375237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.